Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 2/20 | 0.35 |
| ▸ | CMA1 | P23946 | 2/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 5/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ADH5 | P11766 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | BRS3 | P32247 | 1/20 | 0.31 |
| ▸ | KMO | O15229 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18496 | 0.72 | ALDH1A1 (0.40) | ALDH1A1RARBPLA2G2AADH5KMO | |
| SCHEMBL13216898 | 0.66 | SMN1; SMN2 (0.37) | ALDH1A1 | |
| SCHEMBL21479564 | 0.65 | RORC (0.36) | — | |
| SCHEMBL16285376 | 0.65 | CCR1 (0.48) | ALDH1A1RARBPLA2G2AADH5KMO | |
| SCHEMBL10223739 | 0.64 | ALDH1A1 (0.35) | ALDH1A1RARBADH5KMO | |
| SCHEMBL15528727 | 0.64 | EPHX2 (0.37) | ALDH1A1KMO | |
| SCHEMBL21939306 | 0.63 | ALDH1A1 (0.35) | ALDH1A1RARBCMA1KMORARG | |
| SCHEMBL2334939 | 0.63 | KMO (0.41) | ALDH1A1RARBKMO | |
| SCHEMBL604062 | 0.63 | HPGD (0.37) | ALDH1A1RARBCNR1NR1I2BRS3 | |
| SCHEMBL2338992 | 0.63 | RARB (0.37) | ALDH1A1RARBCNR1KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025460-A1 | OXADIAZOLINONE DERIVATIVES AND USE THEREOF IN PEST CONTROL | BAYER CROPSCIENCE AG (DE) | 2012-03-01 | — | — | WO | disclosed |